Get the Stockscreener App
144.09
0.01%
-0.010
After Hours:
144.10
0.010
+0.01%
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $144.09, with a volume of 3.34M.
It is down -0.01% in the last 24 hours and down -1.52% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$144.10
Open:
$142.57
24h Volume:
3.34M
Relative Volume:
1.15
Market Cap:
$63.86B
Revenue:
$9.39B
Net Income/Loss:
$2.62B
P/E Ratio:
24.79
EPS:
5.8121
Net Cash Flow:
$2.22B
1W Performance:
-1.27%
1M Performance:
-1.52%
6M Performance:
-7.87%
1Y Performance:
-19.40%
1-Day Range:
$142.31
$144.68
1-Week Range:
$142.31
$147.93
52-Week Range:
$139.34
$183.11
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jun-18-25 | Downgrade | Stifel | Buy → Hold |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
What consensus target says about Zoetis Inc. (ZOE) stockMarket Activity Recap & Scalable Portfolio Growth Ideas - newser.com
Why analysts remain bullish on Zoetis Inc. stockCEO Change & Daily Market Momentum Tracking - newser.com
2 Magnificent Dividend Stocks to Buy and Hold Forever - The Motley Fool
Technical signs of recovery in Zoetis Inc.July 2025 Short Interest & Weekly Top Gainers Alerts - newser.com
Should You Consider Adding Zoetis (ZTS) to Your Portfolio? - MSN
Can Zoetis Inc. Class stock sustain revenue momentumIPO Watch & Risk Controlled Swing Alerts - newser.com
Zoetis Inc. $ZTS Shares Bought by Kesler Norman & Wride LLC - MarketBeat
10,564 Shares in Zoetis Inc. $ZTS Acquired by GAM Holding AG - MarketBeat
Strs Ohio Acquires 7,870 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Shares Sold by Spire Wealth Management - MarketBeat
Is it time to cut losses on Zoetis Inc.2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com
Is Zoetis Inc. Class stock cheap by valuation metricsWeekly Trading Summary & Daily Growth Stock Investment Tips - newser.com
How Recent Updates Are Rewriting the Story for Zoetis Investors - Yahoo Finance
North Dallas Bank & Trust Co. Invests $922,000 in Zoetis Inc. $ZTS - MarketBeat
Will Zoetis Inc. Class stock top growth indexesRisk Management & Long-Term Safe Investment Ideas - newser.com
Is Zoetis Inc. (ZOE) stock a buy before earnings resultsJuly 2025 Reactions & Verified Stock Trade Ideas - newser.com
Fisher Funds Management LTD Boosts Stock Position in Zoetis Inc. $ZTS - MarketBeat
Amalgamated Bank Boosts Stake in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Shares Sold by Keybank National Association OH - MarketBeat
Published on: 2025-11-01 04:01:24 - newser.com
Published on: 2025-11-01 02:13:46 - newser.com
UNIVEST FINANCIAL Corp Trims Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Stock Position Raised by BLB&B Advisors LLC - MarketBeat
Atria Investments Inc Buys 7,856 Shares of Zoetis Inc. $ZTS - MarketBeat
Hantz Financial Services Inc. Decreases Stake in Zoetis Inc. $ZTS - MarketBeat
World Investment Advisors Sells 2,955 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. (ZTS) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Seeking Clues to Zoetis (ZTS) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics - Yahoo Finance
Zoetis Receives Marketing Authorization for Portela to Alleviate Pain Osteoarthritis Pain in Cats - Pet Age
Ownership Capital B.V. Sells 172,567 Shares of Zoetis Inc. $ZTS - MarketBeat
Motco Buys 4,048 Shares of Zoetis Inc. $ZTS - MarketBeat
Bessemer Group Inc. Sells 3,939 Shares of Zoetis Inc. $ZTS - MarketBeat
AlphaQuest LLC Sells 10,498 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis (ZTS) Gains EU Clearance for Cat Osteoarthritis Treatment - GuruFocus
Is Zoetis Inc. Class stock undervalued at current priceOil Prices & Community Verified Trade Signals - newser.com
Zoetis Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zoetis Gears Up to Report Q3 Earnings: Here's What to Expect - sharewise.com
Ex-Dividend Reminder: Northwest Natural Holding, Cadre Holdings and Zoetis - Nasdaq
Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats - The Joplin Globe
Zoetis Receives European Commission Marketing Authorization for Portela - Business Wire
Zoetis (ZTS) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Increases Stake in Zoetis Inc. $ZTS - MarketBeat
Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth - sharewise.com
Zoetis Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Zoetis Inc. (NYSE:ZTS) Looks Interesting, And It's About To Pay A Dividend - Yahoo Finance
Here's What We Like About Zoetis' (NYSE:ZTS) Upcoming Dividend - simplywall.st
Zoetis Inc. (ZTS) Expands Board with New Appointment - GuruFocus
Zoetis Appoints Stephanie Tilenius to Board of Directors - TipRanks
Zoetis appoints Stephanie Tilenius to its board of directors - MarketScreener
Zoetis Appoints Stephanie Tilenius to its Board of Directors - The AI Journal
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.59%
1.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):